Evidence map›Paper›PMID 41787233›Full record

ArticleJournal of community health2026

Acceptability and Feasibility of Home-Based Human Papillomavirus Self-Testing as Primary Screening for Cervical Cancer Detection in the State of Alabama.

Van Thi Ha Nghiem, Shelita Smith, James Shi, Alexandra McBrayer, Claudia Hardy, Akila Subramaniam, Kevin Fontaine, Renee Heffron, Andrzej Kulczycki

Abstract read
In one paragraph

Article in Journal of community health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Van Thi Ha NghiemUniversity of Alabama at Birmingham School of Public Health, Birmingham, AL, USA. nghiem@uab.edu.ORCID 0000-0002-6994-3571
Shelita SmithUniversity of Alabama at Birmingham School of Public Health, Birmingham, AL, USA.
James ShiUniversity of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
Alexandra McBrayerUniversity of Alabama at Birmingham School of Public Health, Birmingham, AL, USA.
Claudia HardyUniversity of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
Akila SubramaniamUniversity of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
Kevin FontaineUniversity of Alabama at Birmingham School of Public Health, Birmingham, AL, USA.
Renee HeffronUniversity of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
Andrzej KulczyckiUniversity of Alabama at Birmingham School of Public Health, Birmingham, AL, USA.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Treatment of HIV- and HIV+ Patients with HPV16+ CIN2/3 Using pNGLV4a-hCRTE6E7L2 DNA vaccine administered intramuscularly via electroporationP50CA098252 · NCI · JOHNS HOPKINS UNIVERSITY · PI WARNER KING HUH, TZYY-CHOOU WU · 2003 to 2026
$53.5M
Division of Cancer Prevention, National Cancer Institute P50CA098252NCI NIH HHS P50 CA098252NIAID NIH HHS P30 AI027767
6 · The paper itself

Abstract

Alabama has the highest cervical cancer mortality and sixth highest incidence rates nationwide. We assessed the acceptability and feasibility of at-home HPV self-testing for cervical cancer screening in Alabama. Eligible women (ages 30-64y, no Pap last 3.5y, not being pregnant, no hysterectomy history, and satisfying either rural residency or being African American) were recruited by community health workers (CHW), foodbanks, churches, and trusted relationships in targeted communities. Participants received a mailed package including an Evalyn® HPV self-test kit (for analysis against high-risk (HR) HPV-16, -18, and -other HR-groups); and a questionnaire seeking information on health literacy, healthcare experience and attitudes about the HPV self-testing. CHWs recruited 86% of participants. Thirty-five (60%) out of 58 consented-to-participate women returned the completed questionnaires and test kits. Half reported having public insurance, a quarter were uninsured. Half had > 5 sex partners. About 40-77% had incorrect answers to HPV knowledge questions. Ten participants (29%) reported having little trust in doctors. Over 90% of the self-collected samples were analyzable. Three samples were positive with HR-16 and -18 (received referral information for follow-up) but either negative or invalid with other HR-groups, and 29 tests were negative for all HR-groups. Almost all participants (94%) were comfortable with receiving test-kits via mail, and most (83%) preferred home- to clinic-based screening. Overall, HPV self-testing was acceptable among women recruited in community setting. Health literacy, medical trust, and the CHW role can be emphasized in future work to promote HPV self-testing to eliminate cervical cancer.

Indexed as

Early Detection of CancerHuman Papillomavirus VirusesPapillomavirus InfectionsPatient Acceptance of Health CareSelf-TestingUterine Cervical NeoplasmsAdultAlabamaFeasibility StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMiddle AgedSelf CareSurveys and QuestionnairesAccess to careAlabamaCervical cancerHPVSelf-testing

Identifiers

PMID41787233
PMCPMC13223600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.